Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 314

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial

Zavagno, Giorgio, De Salvo, Gian Luca, Scalco, Giuliano, Bozza, Fernando, Barutta, Luca, Del Bianco, Paola, Renier, Marco, Racano, Carlo, Carraro, Paolo, Nitti, Donato·2008·Annals of Surgery

Abstract

In Brief Objective: The aim of this multicenter randomized trial was to assess the efficacy and safety of sentinel lymph node (SLN) biopsy compared with axillary lymph node dissection (ALND). Background: All studies on SLN biopsy in breast cancer report a variable false negative rate, whose prognostic consequences are still unclear. Methods: From May 1999 to December 2004, patients with breast cancer ≤3 cm were randomly assigned to receive SLN biopsy associated with ALND (ALND arm) or SLN biopsy followed by ALND only if the SLN was metastatic (SLN arm). The main aim was the comparison of disease-free survival in the 2 arms. Results: A total of 749 patients were randomized and 697 were available for analysis. SLNs were identified in 662 of 697 patients (95%) and positive SLNs were found in 189 of 662 patients (28.5%). In the ALND group, positive non-SLNs were found in 18 patients with negative SLN, giving a false negative rate of 16.7% (18 of 108). Postoperative side effects were significantly less in the SLN group and there was no negative impact of the SLN procedure on psychologic well being. At a median follow-up of 56 months, there were more locoregional recurrences in the SLN arm, and the 5-year disease-free survival was 89.9% in the ALND arm and 87.6% in the SLN arm, with a difference of 2.3% (95% confidence interval: −3.1% to 7.6%). However, the number of enrolled patients was not sufficient to draw definitive conclusions. Conclusion: SLN biopsy is an effective and well-tolerated procedure. However, its safety should be confirmed by the results of larger randomized trials and meta-analyses. In this randomized study, sentinel node biopsy was compared with axillary dissection in 697 breast cancer patients. The sentinel node identification rate was 95% and the false negative rate was 16.7%. At a median follow-up of 56 months, there were less side effects but more locoregional recurrences in the sentinel node arm.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e31812e6a73

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 314

Metadata

Authors
Zavagno, G., De Salvo, G. L., Scalco, G., Bozza, F., Barutta, L., Del Bianco, P., Renier, M., Racano, C., Carraro, P., & Nitti, D.
Venue
Annals of Surgery
Published
2008-02
Volume
247
Issue
2
Pages
207-213
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2031047702
Cited by
314
References
6
FWCI
7.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial. https://app.cochat.ai/papers/10.1097/sla.0b013e31812e6a73
The paper
Zavagno, G., De Salvo, G. L., Scalco, G., Bozza, F., Barutta, L., Del Bianco, P., Renier, M., Racano, C., Carraro, P., & Nitti, D. (2008). A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial. Annals of Surgery. https://doi.org/10.1097/sla.0b013e31812e6a73

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.